Clincosm LogoSign in Get a demo

Neuroblastoma

Showing NaN - NaN of 91
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)

Active, not recruiting
  • Brain and Central Nervous System Tumors
  • +9 more
  • DNA analysis
  • +4 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 28, 2021

Neuroblastoma Trial in New York (External beam radiotherapy, proton beam RT)

Recruiting
  • Neuroblastoma
  • External beam radiotherapy
  • proton beam RT
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 29, 2021

Neuroblastoma Trial in New York (adjuvant OPT-821 in a vaccine containing two antigens (GD2L and GD3L) covalently linked to KLH,

Active, not recruiting
  • Neuroblastoma
  • adjuvant OPT-821 in a vaccine containing two antigens (GD2L and GD3L) covalently linked to KLH
  • oral β-glucan
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 11, 2021

Neuroblastoma Trial in New York (Humanized 3F8 Monoclonal Antibody (Hu3F8))

Active, not recruiting
  • Neuroblastoma
  • Humanized 3F8 Monoclonal Antibody (Hu3F8)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 24, 2021

Neuroblastoma Trial in Worldwide (carboplatin, cyclophosphamide, doxorubicin HCl)

Completed
Has Results
  • Neuroblastoma
  • Birmingham, Alabama
  • +188 more
Jul 1, 2021

Brain Tumor, CNS Tumor, Childhood Germ Cell Tumor Trial in Australia, Canada, United States (sodium thiosulfate, examination)

Completed
Has Results
  • Brain Tumor
  • +8 more
  • sodium thiosulfate
  • examination
  • Birmingham, Alabama
  • +75 more
Jul 1, 2021

Neuroblastoma Trial in New York (3F8 Monoclonal Antibody Combined with Interleukin-2)

Completed
  • Neuroblastoma
  • 3F8 Monoclonal Antibody Combined with Interleukin-2
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 26, 2021

Neuroblastoma Trial in New York (Anti-GD2 3F8 Monoclonal Antibody, GM-CSF (granulocyte-macrophage colony-stimulating factor),

Completed
Has Results
  • Neuroblastoma
  • Anti-GD2 3F8 Monoclonal Antibody
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 17, 2020

Neuroblastoma, Rhabdomyosarcoma, Ewing's Sarcoma Trial in Worldwide (nab-paclitaxel)

Completed
Has Results
  • Neuroblastoma
  • +22 more
  • Phoenix, Arizona
  • +19 more
Dec 19, 2019

Sarcoma, Wilm's Tumor, Lymphoma Trial in Bethesda, Boston, New York (Ipilimumab)

Completed
  • Sarcoma
  • +3 more
  • Bethesda, Maryland
  • +2 more
Dec 14, 2019

Malignant Rhabdoid Tumors (MRT), Neuroblastoma Trial in Worldwide (LEE011)

Terminated
Has Results
  • Malignant Rhabdoid Tumors (MRT)
  • Neuroblastoma
  • San Francisco, California
  • +12 more
Nov 13, 2019

Neuroblastoma Trial in New York (Bevacizumab, Irinotecan and Temozolomide)

Completed
Has Results
  • Neuroblastoma
  • Bevacizumab, Irinotecan and Temozolomide
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 12, 2019

Neuroblastoma Trial in New York (3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid)

Terminated
Has Results
  • Neuroblastoma
  • 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Nov 12, 2019

Neuroblastoma, Sarcoma Trial in Canada, United States (Cyclophosphamide, Topotecan, and Bevacizumab)

Completed
Has Results
  • Neuroblastoma
  • Sarcoma
  • Cyclophosphamide, Topotecan, and Bevacizumab
  • Phoenix, Arizona
  • +6 more
Oct 28, 2019

Neuroblastoma Trial in New York (3F8 mAb and 13-cis-Retinoic Acid)

Completed
Has Results
  • Neuroblastoma
  • 3F8 monoclonal antibody and 13-cis-Retinoic Acid
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Sep 16, 2019

Neuroblastoma Trial in New York (3F8 and 13-cis-retinoic acid)

Completed
Has Results
  • Neuroblastoma
  • 3F8 and 13-cis-retinoic acid
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 24, 2019

Neuroblastoma Trial in New York (3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic)

Completed
Has Results
  • Neuroblastoma
  • 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jul 24, 2019

Immunogenicity and Safety of Unituxin® in High-Risk

Terminated
Has Results
  • Neuroblastoma
  • Birmingham, Alabama
  • +17 more
Jun 11, 2019

Leukemia, Lymphoma, Neuroblastoma Trial in New York (Alemtuzumab, Total Body Irradiation, Melphalan)

Terminated
Has Results
  • Leukemia
  • +4 more
  • New York, New York
    Columbia Presbyterian Medical Center
Mar 4, 2019

Neuroblastoma, Bone Marrow, Sympathetic Nervous System Trial in New York (cyclophosphamide, vincristine, topotecan ,allogeneic

Completed
  • Neuroblastoma
  • Bone Marrow, Sympathetic Nervous System
  • cyclophosphamide, vincristine, topotecan ,allogeneic NK cells & 3F8
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 9, 2019

Neuroblastoma

Completed
  • Neuroblastoma
  • Cytology Specimen Collection Procedure
  • +2 more
  • Birmingham, Alabama
  • +152 more
Jan 4, 2019

Neuroblastoma Trial in Worldwide (biological, drug, procedure, radiation)

Completed
  • Neuroblastoma
  • filgrastim
  • +8 more
  • Birmingham, Alabama
  • +234 more
Mar 9, 2017

CNS Cancer, Neuroblastoma, Sarcoma Trial in New York (131I-8H9, 8H9)

Terminated
Has Results
  • CNS Cancer
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 10, 2017

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Non-Hodgkins Lymphoma Trial in United States (Food Safety Guidelines,

Completed
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Food Safety Guidelines
  • Neutropenic Diet
  • San Diego, California
  • +5 more
Feb 7, 2017

Neuroblastoma Trial in Canada, United States (fenretinide, high performance liquid chromatography, pharmacological study)

Completed
  • Neuroblastoma
  • Los Angeles, California
  • +12 more
Dec 20, 2016